These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31765841)

  • 1. Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion.
    Ullah N; Ma FR; Han J; Liu XL; Fu Y; Liu YT; Liang YL; Ouyang H; Li HY
    Mol Immunol; 2020 Jan; 117():122-130. PubMed ID: 31765841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action.
    Fujita M; Takada YK; Izumiya Y; Takada Y
    PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications.
    Suresh MV; Singh SK; Agrawal A
    J Biol Chem; 2004 Dec; 279(50):52552-7. PubMed ID: 15456743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions.
    Eisenhardt SU; Starke J; Thiele JR; Murphy A; Björn Stark G; Bassler N; Sviridov D; Winkler K; Peter K
    Atherosclerosis; 2012 Oct; 224(2):384-93. PubMed ID: 22901456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine Inhibits Monomeric C-Reactive Protein Induced Inflammation, Endothelial Cell Adhesion, and Platelet Aggregation; A Potential Therapeutic?
    Slevin M; Iemma RS; Zeinolabediny Y; Liu D; Ferris GR; Caprio V; Phillips N; Di Napoli M; Guo B; Zeng X; AlBaradie R; Binsaleh NK; McDowell G; Fang WH
    Front Immunol; 2018; 9():2124. PubMed ID: 30319609
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
    Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
    Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A redox switch in C-reactive protein modulates activation of endothelial cells.
    Wang MY; Ji SR; Bai CJ; El Kebir D; Li HY; Shi JM; Zhu W; Costantino S; Zhou HH; Potempa LA; Zhao J; Filep JG; Wu Y
    FASEB J; 2011 Sep; 25(9):3186-96. PubMed ID: 21670067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of human C-reactive protein (CRP) to plasma fibronectin occurs via the phosphorylcholine-binding site.
    Tseng J; Mortensen RF
    Mol Immunol; 1988 Aug; 25(8):679-86. PubMed ID: 2460754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
    Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
    FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and inflammation: conformational changes affect function.
    Wu Y; Potempa LA; El Kebir D; Filep JG
    Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: how conformational changes influence inflammatory properties.
    Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K
    Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role?
    Køstner AH; Fuglestad AJ; Georgsen JB; Nielsen PS; Christensen KB; Zibrandtsen H; Parner ET; Rajab IM; Potempa LA; Steiniche T; Kersten C
    Front Immunol; 2023; 14():1170443. PubMed ID: 37006231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion.
    Zouki C; Haas B; Chan JS; Potempa LA; Filep JG
    J Immunol; 2001 Nov; 167(9):5355-61. PubMed ID: 11673552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.
    Ullah N; Wu Y
    Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells.
    Khreiss T; József L; Potempa LA; Filep JG
    Circulation; 2004 Apr; 109(16):2016-22. PubMed ID: 15051635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native and modified C-reactive protein bind different receptors on human neutrophils.
    Heuertz RM; Schneider GP; Potempa LA; Webster RO
    Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidic pH promotes oxidation-induced dissociation of C-reactive protein.
    Li SL; Feng JR; Zhou HH; Zhang CM; Lv GB; Tan YB; Ge ZB; Wang MY
    Mol Immunol; 2018 Dec; 104():47-53. PubMed ID: 30408622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of model soluble immune complexes to modified C-reactive protein.
    Motie M; Brockmeier S; Potempa LA
    J Immunol; 1996 Jun; 156(11):4435-41. PubMed ID: 8666818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages.
    Sproston NR; El Mohtadi M; Slevin M; Gilmore W; Ashworth JJ
    Front Immunol; 2018; 9():1500. PubMed ID: 30013561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.